This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
DEST Overzicht aandelen
A biotechnology company, focuses on the discovery, development, and commercialization of anti infectives in the United Kingdom.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 0/6 |
Destiny Pharma plc Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | UK£0.03 |
| 52 Week Hoogtepunt | UK£0.84 |
| 52 Week Laag | UK£0.02 |
| Bèta | 0.22 |
| 11 maand verandering | -7.69% |
| 3 maanden verandering | -81.54% |
| 1 Jaar Verandering | -93.75% |
| 33 jaar verandering | -97.59% |
| 5 jaar verandering | -92.21% |
| Verandering sinds IPO | -98.62% |
Recent nieuws en updates
Recent updates
We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely
Jan 12
Destiny Pharma (LON:DEST) Is In A Good Position To Deliver On Growth Plans
Sep 26We Think Destiny Pharma (LON:DEST) Needs To Drive Business Growth Carefully
May 26Companies Like Destiny Pharma (LON:DEST) Are In A Position To Invest In Growth
Feb 01Will Destiny Pharma (LON:DEST) Spend Its Cash Wisely?
Aug 05Is Destiny Pharma (LON:DEST) In A Good Position To Invest In Growth?
Apr 16What Type Of Shareholders Make Up Destiny Pharma plc's (LON:DEST) Share Registry?
Feb 11
We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely
Nov 30Rendement voor aandeelhouders
| DEST | GB Biotechs | GB Markt | |
|---|---|---|---|
| 7D | -14.3% | 1.2% | 1.1% |
| 1Y | -93.8% | -13.5% | 11.5% |
Rendement versus industrie: DEST underperformed the UK Biotechs industry which returned -22.1% over the past year.
Rendement versus markt: DEST underperformed the UK Market which returned 7.3% over the past year.
Prijsvolatiliteit
| DEST volatility | |
|---|---|
| DEST Average Weekly Movement | 35.6% |
| Biotechs Industry Average Movement | 8.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stabiele aandelenkoers: DEST's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: DEST's weekly volatility has increased from 21% to 36% over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1996 | 15 | Chris Tovey | www.destinypharma.com |
Destiny Pharma plc Samenvatting
| DEST fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | UK£4.55m |
| Inkomsten(TTM) | -UK£5.66m |
| Inkomsten(TTM) | UK£831.55k |
3.5x
P/S-verhouding-0.5x
Koers/WinstverhoudingIs DEST overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| DEST resultatenrekening (TTM) | |
|---|---|
| Inkomsten | UK£831.55k |
| Kosten van inkomsten | UK£0 |
| Brutowinst | UK£831.55k |
| Overige uitgaven | UK£6.49m |
| Inkomsten | -UK£5.66m |
Laatst gerapporteerde inkomsten
Dec 31, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.059 |
| Brutomarge | 100.00% |
| Nettowinstmarge | -680.30% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde DEST op de lange termijn?
Bekijk historische prestaties en vergelijking